Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've been searching for a Mounjaro price reduction, the honest answer is that UK private costs moved in the opposite direction from September 2025. Eli Lilly raised the list price of Mounjaro significantly, with the highest-dose pen rising from around £122 to around £330 per four-week supply. That shift was widely reported at the time and has reshaped what private providers charge across the board. Mounjaro (tirzepatide) is a prescription-only medicine requiring clinical assessment before any prescription is issued, which means the price you pay through a legitimate provider always reflects more than just the pen itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before comparing prices, it helps to know why private costs are where they are. In August 2025, Eli Lilly announced a significant UK list-price increase, effective from 1 September 2025. The per-pen cost rose sharply at higher doses, the 15mg pen's list price increased from roughly £122 to roughly £330. Providers who source through the licensed UK supply chain passed that increase on. Any advertised price that looks dramatically lower than this range is worth scrutinising carefully.
Private weight-loss treatment is priced per pen (each pen covers four weekly doses) and varies by dose and provider. Reported private prices since September 2025 typically range from around £149 to £375 a month depending on the dose and clinic. Those figures are the honest market context, and they are the only per-pen price figures you will find on this page, current pricing details are shown on the treatment page, where they can be kept up to date accurately.
Worth noting: a Mounjaro price reduction in the UK market would require a shift at manufacturer level. No credible reduction has been announced as of the date this page was published. Any seller offering significant discounts off current market rates without explanation deserves a second look.
This is where private Mounjaro pricing gets genuinely complicated. A low monthly figure sometimes covers only the pen. Consultation fees, prescription charges, delivery costs and any aftercare or dose-review support can each be charged separately. Add them together and the advertised price looks quite different.
It is also worth asking whether the provider includes clinical re-review before each repeat order. A prescription is not a standing order, every repeat should involve a real assessment of your progress, side effects and current dose, not just a click-through checkout. Providers that skip this step can keep their headline prices tidier, but that is not a saving that benefits you.
If you want a breakdown of what providers typically charge for each dose, the Mounjaro injection price guide lays it out by starting dose, and there is separate detail on the 2.5mg starter pen for anyone beginning treatment. The 5mg step is covered on the 5mg price page.
nume is not the cheapest option in the UK private market. That is a deliberate choice, not an oversight. One transparent price covers the free consultation, the prescription, the medicine, and free next-working-day delivery by DPD, tracked, to your door, in packaging that gives nothing away. There are no hidden fees at any stage and no subscription that renews without you choosing to continue. Every repeat order goes through fresh clinical review before anything is dispatched.
Order by 12pm Monday to Friday and, once a prescriber has reviewed and approved your consultation, your treatment is dispatched the same day. For many patients that means it arrives before the school run the following morning. Your consultation is reviewed personally by a GPhC-registered Independent Prescriber, a real clinician reads your answers and makes a clinical decision, not automated software.
If the concept of a lower-cost Mounjaro route is genuinely important to you, that page explores the options honestly. For a broader sense of what our service involves, the about us page sets out how we work and who our clinical team is.
For any prescription medicine, the cheapest listing answers the wrong question. The MHRA has warned publicly about fake weight-loss pens sold without a prescription through social media and unverified websites. Counterfeit tirzepatide pens have been found in the UK supply chain, and in 2025 enforcement action included the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million, and the raid of an illicit manufacturing site producing counterfeit pens. The MHRA's Yellow Card scheme allows anyone to report a suspect seller.
The right questions are: is this pharmacy registered with the GPhC? Is a prescriber actually reviewing my case? Is the medicine coming through a licensed UK supply chain? You can verify any online pharmacy on the GPhC register, our premises registration number is 9012878. A small saving is not the measure that keeps you safe on a treatment like this.
You can also explore what the discount and reduced-price landscape for Mounjaro actually looks like in the UK, and whether any of those routes hold up to scrutiny. For people weighing all their options together, the weight-loss treatment overview is a good starting point before a consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.